ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Flow Cytometric Analysis of Leukocyte Migration during Ex Vivo Lung Perfusion with CXCR4 Inhibition

J. Yerxa1, Q. Gao1, R. P. Davis2, M. Zhang1, U. Scheuermann1, W. Parker1, M. G. Hartwig2, A. Barbas1

1General Surgery, Duke University, Durham, NC, 2Thoracic Surgery, Duke University, Durham, NC

Meeting: 2019 American Transplant Congress

Abstract number: A98

Keywords: Lung, Lung preservation, Perfusion solutions

Session Information

Session Name: Poster Session A: Ischemia Reperfusion & Organ Rehabilition

Session Type: Poster Session

Date: Saturday, June 1, 2019

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Hall C & D

*Purpose: Ex vivo lung perfusion (EVLP) has emerged as a preservation technique utilized to evaluate candidate donor lungs in a metabolically active state. This also provides a platform for potential allograft reconditioning. Donor leukocytes have been implicated in ischemia reperfusion injury, primary graft dysfunction, and acute rejection. Pharmacologic strategies to enhance donor leukocyte depletion during EVLP have not yet been described. Plerixafor is a clinically available CXCR4 antagonist, blocking the interaction between CXCR4 and SDF-1α. We tested the hypothesis that plerixafor improves donor leukocyte depletion during ex vivo perfusion.

*Methods: The Duke University Institutional Animal Care and Use Committee (IACUC) approved all animal protocols. Rats were housed in standard climate controlled, pathogen free conditions. Heart-lung blocs procured from Lewis rats (225-275g, Charles River) were subjected to 3 hours of normothermic EVLP with Steen Solution (XVIVO) with (N=5) or without (N=6) the addition of plerixafor. Cell counts (cells/μL) were determined using BD Trucount tubes and analyzed using a LSR II flow cytometer (BD Biosciences). Student’s t-test was applied for determination of statistical significance. A probability of less than 0.5 (P <0.05) was considered statistically significant. Statistics were run with GraphPad Prism version 8.

*Results: Leukocytes depleted from the lung during perfusion are expressed as the number of CD45+ cells in the perfusate over the total number of CD45+ cells in the perfusate plus the lung (mean ± SEM). Plerixafor delivered during EVLP (n=5) did not alter leukocyte depletion compared to standard EVLP (n=6) (27.83±5.62% vs. 46.81±7.56%, p=0.084). Proportions of cell populations mobilized into the perfusate were consistent among subjects and groups. Similar proportions of B-cells (25.76±0.93% vs. 30.52±1.74%, p=0.052), T-cells (48.37±2.64% vs. 47.86±0.77%, p=0.845), and neutrophils (1.91±0.52% vs. 1.93±0.55%, p=0.976) were detected in the perfusate regardless of subjects total cell counts or study group (Figure 1). This suggests that flow cytometric analysis was accurate and reproducible for this application.

*Conclusions: Plerixafor does not increase donor leukocyte depletion during EVLP in this rodent model. Flow cytometric analysis of perfusate can provide a novel method of identifying and quantifying specific cell populations during ex vivo perfusion, and will be a useful tool as leukocyte depletion is studied further.

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Yerxa J, Gao Q, Davis RP, Zhang M, Scheuermann U, Parker W, Hartwig MG, Barbas A. Flow Cytometric Analysis of Leukocyte Migration during Ex Vivo Lung Perfusion with CXCR4 Inhibition [abstract]. Am J Transplant. 2019; 19 (suppl 3). https://atcmeetingabstracts.com/abstract/flow-cytometric-analysis-of-leukocyte-migration-during-ex-vivo-lung-perfusion-with-cxcr4-inhibition/. Accessed May 9, 2025.

« Back to 2019 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences